VX-765 enhances autophagy of human umbilical cord mesenchymal stem cells against stroke-induced apoptosis and inflammatory responses via AMPK/mTOR signaling pathway

25Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction: To investigate the protective effect of VX-765 on human umbilical mesenchymal stem cells (HUMSCs) in stroke and its mechanism. Materials and methods: Mouse models of ischemic stroke were established using the distal middle cerebral artery occlusion (dMCAO) method. The dMCAO mice were accordingly transplanted with HUMSCs, VX-765-treated HUMSCs, or VX-765 + MHY185-treated HUMSCs. The HUMSCs were inserted with green fluorescent protein (GFP) for measurement of transplantation efficiency which was determined by immunofluorescence assay. Oxygen-glucose deprivation (OGD) was applied to mimic ischemic environment in vitro experiments, and the HUMSCs herein were transfected with AMPK inhibitor Compound C or autophagy inhibitor 3-MA. MTT assay was used to test the toxicity of VX-765. TUNEL staining and ELISA were applied to measure the levels of apoptosis and inflammatory cytokines (IL-1β, IL-6, and IL-10), respectively. The expressions of autophagy-associated proteins, AMPK, and mTOR were detected by Western blotting. TTC staining was applied to reveal the infarct lesions in the brain of dMCAO mice. Results: The pro-inflammatory cytokines, TUNEL-positive cells, and p-mTOR were decreased while the anti-inflammatory cytokine, autophagy-related proteins, and p-AMPK were increased in HUMSCs treated with VX-765 under OGD condition. Different expression patterns were found with the above factors after transfection of 3-MA or Compound C. The pro-inflammatory cytokines, TUNEL-positive cells, and infarct sections were decreased while the anti-inflammatory cytokine and autophagy-related proteins were increased in dMCAO mice transplanted with VX-765-treated HUMSCs compared to those transplanted with HUMSCs only. The autophagy was inhibited while p-mTOR was up-regulated after transfection of MHY. Conclusion: VX-765 protects HUMSCs against stroke-induced apoptosis and inflammatory responses by activating autophagy via the AMPK/mTOR signaling pathway in vivo and in vitro.

References Powered by Scopus

Heart Disease and Stroke Statistics'2017 Update: A Report from the American Heart Association

7472Citations
N/AReaders
Get full text

Randomized assessment of rapid endovascular treatment of ischemic stroke

5048Citations
N/AReaders
Get full text

Targeting autophagy in cancer

2043Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics

199Citations
N/AReaders
Get full text

Neurovascular Unit: A critical role in ischemic stroke

112Citations
N/AReaders
Get full text

Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke

106Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sun, Z., Gu, L., Wu, K., Wang, K., Ru, J., Yang, S., … Huang, S. (2020). VX-765 enhances autophagy of human umbilical cord mesenchymal stem cells against stroke-induced apoptosis and inflammatory responses via AMPK/mTOR signaling pathway. CNS Neuroscience and Therapeutics, 26(9), 952–961. https://doi.org/10.1111/cns.13400

Readers over time

‘20‘21‘22‘23‘24‘25036912

Readers' Seniority

Tooltip

Professor / Associate Prof. 2

40%

Lecturer / Post doc 1

20%

PhD / Post grad / Masters / Doc 1

20%

Researcher 1

20%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

43%

Biochemistry, Genetics and Molecular Bi... 2

29%

Nursing and Health Professions 1

14%

Neuroscience 1

14%

Save time finding and organizing research with Mendeley

Sign up for free
0